secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2026-03-09T23:59:59+00:00
Accession:  0001493152-26-009382
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell shareholders ratify auditor, elect six directors, approve equity plan at AGM
--------------------------------------------------------------------------------

- MNP LLP ratified as auditor with 3,431,761 for, 70,934 against.
- Six directors elected: Gross, Bondarenko, Williams, Taub, Embro-Pantalony, Schmieg. For votes ranged from ~1.837M to ~1.848M.
- Omnibus equity incentive plan re-approved: 1,524,081 for, 362,949 against (51% of shares voted).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315226009382/0001493152-26-009382-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315226009382/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-009382

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer